BioCentury
ARTICLE | Financial News

Israel's BioLineRx planning U.S. listing

September 28, 2010 12:03 AM UTC

BioLineRx Ltd. (Tel Aviv:BLRX) proposed to list its shares on NASDAQ and raise up to $40.3 million in a financing underwritten by JMP Securities and Oppenheimer. BioLineRx's CYP-1020 (formerly BL-1020...